SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-23-008431
Filing Date
2023-11-22
Accepted
2023-11-22 17:01:23
Documents
1
Period of Report
2023-11-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3927
  Complete submission text file 0001683168-23-008431.txt   5510
Mailing Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653
Business Address 23046 AVENIDA DE LA CARLOTA, SUITE 600 LAGUNA HILLS CA 92653 (917) 595.2850
PharmaCyte Biotech, Inc. (Issuer) CIK: 0001157075 (see all company filings)

IRS No.: 621772151 | State of Incorp.: NV | Fiscal Year End: 0430
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address IROQUOIS CAPITAL MANAGEMENT LLC 205 EAST 42ND ST - 20TH FL. NEW YORK NY 10017
Business Address
Silverman Joshua (Reporting) CIK: 0001524858 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40699 | Film No.: 231434244